News and Press Releases Search About the CF Foundation Genetic Therapies Public Policy Research Advocacy Drug Pipeline NACFC Care Centers CF Related Health Conditions Clinical Trials Fundraising Health Care Reform (-) CFTR Modulators 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 (-) 2011 2010 2009 2008 News Press Releases About the CF Foundation | CFTR Modulators | Genetic Therapies FDA Grants Six-Month Priority Review of Kalydeco (VX-770) — First Potential Drug to Target Underlying Cause of Cystic Fibrosis Dec. 15, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies New Hope of Kalydeco (VX-770) Makes Headlines and Newscasts Around the Nation Nov. 8, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Cystic Fibrosis Foundation Issues Statement on The New England Journal of Medicine Study Showing Evidence of Success in Treating Underlying Cause of Cystic Fibrosis Nov. 2, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Wall Street Journal Health Blog: CF Foundation Not Just a Cheerleader Oct. 25, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies New Cystic Fibrosis Drug Brings Gift of a Future, NPR Reports Online May. 6, 2011 | 1 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Bloomberg Businessweek Highlights Promise of Potential Drug VX-770 Mar. 22, 2011 | 2 min read About the CF Foundation | CFTR Modulators | Genetic Therapies The New York Times and Other Major Media Outlets Feature Results of VX-770 Trial Mar. 4, 2011 | 2 min read
